These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16238713)

  • 1. Antiepileptic drug discovery: lessons from the past and future challenges.
    Klitgaard H
    Acta Neurol Scand Suppl; 2005; 181():68-72. PubMed ID: 16238713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levetiracetam: the preclinical profile of a new class of antiepileptic drugs?
    Klitgaard H
    Epilepsia; 2001; 42 Suppl 4():13-8. PubMed ID: 11564119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam.
    Kaminski RM; Matagne A; Patsalos PN; Klitgaard H
    Epilepsia; 2009 Mar; 50(3):387-97. PubMed ID: 18627416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment.
    Klitgaard H; Matagne A; Nicolas JM; Gillard M; Lamberty Y; De Ryck M; Kaminski RM; Leclercq K; Niespodziany I; Wolff C; Wood M; Hannestad J; Kervyn S; Kenda B
    Epilepsia; 2016 Apr; 57(4):538-48. PubMed ID: 26920914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam: a new therapeutic option for refractory epilepsy.
    Pinto A; Sander JW
    Int J Clin Pract; 2003 Sep; 57(7):616-21. PubMed ID: 14529064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiepileptogenesis, neuroprotection, and disease modification in the treatment of epilepsy: focus on levetiracetam.
    Klitgaard H; Pitkänen A
    Epileptic Disord; 2003 May; 5 Suppl 1():S9-16. PubMed ID: 12915336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proepileptic phenotype of SV2A-deficient mice is associated with reduced anticonvulsant efficacy of levetiracetam.
    Kaminski RM; Gillard M; Leclercq K; Hanon E; Lorent G; Dassesse D; Matagne A; Klitgaard H
    Epilepsia; 2009 Jul; 50(7):1729-40. PubMed ID: 19486357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiepileptic drugs and neuroprotection: current status and future roles.
    Willmore LJ
    Epilepsy Behav; 2005 Dec; 7 Suppl 3():S25-8. PubMed ID: 16239127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brivaracetam: a rational drug discovery success story.
    Rogawski MA
    Br J Pharmacol; 2008 Aug; 154(8):1555-7. PubMed ID: 18552880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis.
    Luszczki JJ; Andres MM; Czuczwar P; Cioczek-Czuczwar A; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Epilepsia; 2006 Jan; 47(1):10-20. PubMed ID: 16417526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levetiracetam in brain ischemia: clinical implications in neuroprotection and prevention of post-stroke epilepsy.
    Belcastro V; Pierguidi L; Tambasco N
    Brain Dev; 2011 Apr; 33(4):289-93. PubMed ID: 20630672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of epileptogenesis and preclinical approach to antiepileptogenic therapies.
    Łukawski K; Andres-Mach M; Czuczwar M; Łuszczki JJ; Kruszyński K; Czuczwar SJ
    Pharmacol Rep; 2018 Apr; 70(2):284-293. PubMed ID: 29477036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs.
    Löscher W
    Seizure; 2011 Jun; 20(5):359-68. PubMed ID: 21292505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why are antiepileptic drugs used for nonepileptic conditions?
    Bialer M
    Epilepsia; 2012 Dec; 53 Suppl 7():26-33. PubMed ID: 23153207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiepileptic treatment in paediatric oncology--an interdisciplinary challenge.
    Tibussek D; Distelmaier F; Schönberger S; Göbel U; Mayatepek E
    Klin Padiatr; 2006; 218(6):340-9. PubMed ID: 17080337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticonvulsant properties of the novel nootropic agent nefiracetam in seizure models of mice and rats.
    Kitano Y; Komiyama C; Makino M; Takasuna K; Takazawa A; Sakurada S
    Epilepsia; 2005 Jun; 46(6):811-8. PubMed ID: 15946322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seizure control with antiepileptic drug therapy in 517 consecutive adult outpatients at the Kork Epilepsy Centre.
    Steinhoff BJ; Maren Staack A; Wisniewski I
    Epileptic Disord; 2012 Dec; 14(4):379-87. PubMed ID: 23274162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Levetiracetam.
    Krishna K; Raut AL; Gohel KH; Dave P
    J Assoc Physicians India; 2011 Oct; 59():656-8. PubMed ID: 22479748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary efficacy of levetiracetam in monotherapy.
    Ben-Menachem E
    Epileptic Disord; 2003 May; 5 Suppl 1():S51-5. PubMed ID: 12915342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of levetiracetam use following resective surgery in patients with refractory epilepsy: a prospective observational study.
    Zeng TF; Li YH; An DM; Chen L; Lei D; Zhang B; Li JM; Zhou D
    Epilepsy Res; 2014 Dec; 108(10):1904-11. PubMed ID: 25454502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.